-
Je něco špatně v tomto záznamu ?
AGR2 associates with HER2 expression predicting poor outcome in subset of estrogen receptor negative breast cancer patients
E. Ondrouskova, L. Sommerova, R. Nenutil, O. Coufal, P. Bouchal, B. Vojtesek, R. Hrstka,
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články
- MeSH
- lidé MeSH
- messenger RNA genetika metabolismus MeSH
- nádorové buněčné linie MeSH
- nádory prsu diagnóza genetika MeSH
- prognóza MeSH
- proliferace buněk MeSH
- proteiny genetika metabolismus MeSH
- receptor erbB-2 genetika MeSH
- receptory pro estrogeny genetika MeSH
- regulace genové exprese u nádorů * MeSH
- up regulace MeSH
- Check Tag
- lidé MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
Expression of the AGR2 oncogene was shown to be associated with estrogen receptor positive tumors. This gene contributes to enhanced cellular proliferation, drug resistance, metastasis development and may also serve as a predictor of poor prognosis. However, our analysis of AGR2 expression in a subset of estrogen-receptor negative tumors revealed that AGR2 could also be upregulated in hormone-independent manner. AGR2 expression was shown to be significantly increased in HER2 positive breast tumors on both the mRNA and the protein level. Moreover, in a subset of estrogen- and progesterone-receptor negative and simultaneously HER2-positive cases, increased AGR2 expression significantly correlated with worse patient prognosis. Subsequent analysis of independent data sets either collected in our institute or obtained from Oncomine cancer microarray database confirmed all these findings.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17031006
- 003
- CZ-PrNML
- 005
- 20190204090657.0
- 007
- ta
- 008
- 171025s2017 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.yexmp.2017.02.016 $2 doi
- 035 __
- $a (PubMed)28238761
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Ondrouskova, Eva $u Masaryk Memorial Cancer Institute, RECAMO, Zluty kopec 7, 656 53 Brno, Czech Republic.
- 245 10
- $a AGR2 associates with HER2 expression predicting poor outcome in subset of estrogen receptor negative breast cancer patients / $c E. Ondrouskova, L. Sommerova, R. Nenutil, O. Coufal, P. Bouchal, B. Vojtesek, R. Hrstka,
- 520 9_
- $a Expression of the AGR2 oncogene was shown to be associated with estrogen receptor positive tumors. This gene contributes to enhanced cellular proliferation, drug resistance, metastasis development and may also serve as a predictor of poor prognosis. However, our analysis of AGR2 expression in a subset of estrogen-receptor negative tumors revealed that AGR2 could also be upregulated in hormone-independent manner. AGR2 expression was shown to be significantly increased in HER2 positive breast tumors on both the mRNA and the protein level. Moreover, in a subset of estrogen- and progesterone-receptor negative and simultaneously HER2-positive cases, increased AGR2 expression significantly correlated with worse patient prognosis. Subsequent analysis of independent data sets either collected in our institute or obtained from Oncomine cancer microarray database confirmed all these findings.
- 650 _2
- $a nádory prsu $x diagnóza $x genetika $7 D001943
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 _2
- $a proliferace buněk $7 D049109
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 12
- $a regulace genové exprese u nádorů $7 D015972
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a prognóza $7 D011379
- 650 _2
- $a proteiny $x genetika $x metabolismus $7 D011506
- 650 _2
- $a messenger RNA $x genetika $x metabolismus $7 D012333
- 650 _2
- $a receptor erbB-2 $x genetika $7 D018719
- 650 _2
- $a receptory pro estrogeny $x genetika $7 D011960
- 650 _2
- $a up regulace $7 D015854
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Sommerová, Lucia $u Masaryk Memorial Cancer Institute, RECAMO, Zluty kopec 7, 656 53 Brno, Czech Republic. $7 xx0223970
- 700 1_
- $a Nenutil, Rudolf $u Masaryk Memorial Cancer Institute, RECAMO, Zluty kopec 7, 656 53 Brno, Czech Republic.
- 700 1_
- $a Coufal, Oldrich $u Masaryk Memorial Cancer Institute, RECAMO, Zluty kopec 7, 656 53 Brno, Czech Republic.
- 700 1_
- $a Bouchal, Pavel, $u Masaryk Memorial Cancer Institute, RECAMO, Zluty kopec 7, 656 53 Brno, Czech Republic. $d 1975- $7 xx0128495
- 700 1_
- $a Vojtesek, Borivoj $u Masaryk Memorial Cancer Institute, RECAMO, Zluty kopec 7, 656 53 Brno, Czech Republic.
- 700 1_
- $a Hrstka, Roman $u Masaryk Memorial Cancer Institute, RECAMO, Zluty kopec 7, 656 53 Brno, Czech Republic. Electronic address: hrstka@mou.cz.
- 773 0_
- $w MED00001738 $t Experimental and molecular pathology $x 1096-0945 $g Roč. 102, č. 2 (2017), s. 280-283
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28238761 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20171025 $b ABA008
- 991 __
- $a 20190204090934 $b ABA008
- 999 __
- $a ok $b bmc $g 1254599 $s 992033
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 102 $c 2 $d 280-283 $e 20170224 $i 1096-0945 $m Experimental and molecular pathology $n Exp Mol Pathol $x MED00001738
- LZP __
- $a Pubmed-20171025
